Spyre Therapeutics Inc (SYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -35,186 | -17,167 | -44,348 | -29,450 | -17,533 |
| Depreciation Amortization | -336 | -175 | -300 | -90 | 38 |
| Accounts receivable | N/A | N/A | 3,078 | 656 | -1,203 |
| Accounts payable and accrued liabilities | 2,141 | 2,289 | 239 | 727 | 579 |
| Other Working Capital | 335 | 142 | 7,201 | 1,028 | -1,249 |
| Other Operating Activity | 856 | -896 | 1,937 | 2,136 | 2,877 |
| Operating Cash Flow | $-32,190 | $-15,807 | $-32,193 | $-24,993 | $-16,491 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -27,902 | 14,054 | -14,809 | -12,880 | -14,380 |
| PPE Investments | -175 | -118 | -422 | -219 | -118 |
| Investing Cash Flow | $-28,077 | $13,936 | $-15,231 | $-13,099 | $-14,498 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -12 | -6 | N/A | 0 | 0 |
| Common Stock Issued | 64,748 | 65,061 | 57,068 | 39,807 | 1,061 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 37,690 |
| Financing Cash Flow | $64,736 | $65,055 | $57,068 | $39,807 | $38,751 |
| Beginning Cash Position | 22,461 | 22,461 | 12,817 | 12,817 | 12,817 |
| End Cash Position | 26,930 | 85,645 | 22,461 | 14,532 | 20,579 |
| Net Cash Flow | $4,469 | $63,184 | $9,644 | $1,715 | $7,762 |
| Free Cash Flow | |||||
| Operating Cash Flow | -32,190 | -15,807 | -32,193 | -24,993 | -16,491 |
| Capital Expenditure | -175 | -118 | -422 | -219 | -118 |
| Free Cash Flow | -32,365 | -15,925 | -32,615 | -25,212 | -16,609 |